Testicular Yolk Sac Tumor
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Testicular Yolk Sac Tumor

What is the definition of Testicular Yolk Sac Tumor?
Testicular yolk sac tumor is a subtype of testicular cancer that most commonly occurs in the testicles of young and middle-age men. While the exact cause is not well understood, some risk factors have been determined, such as undescended testicle, abnormal testicle development, smoking, exposure to some chemicals, family history of testicular cancer, HIV infection, and Down syndrome.
What are the symptoms of Testicular Yolk Sac Tumor?
Testicular yolk sac tumor may have no symptoms or appear as a painless mass in the testes. If symptoms occur, they may include discomfort or pain, or a sense of heaviness in the scrotum, lower back of abdominal pain, an enlarged testicle, or an overgrowth of male breast tissue. The cancer may spread to other parts of the body.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Testicular Yolk Sac Tumor?
Treatment for testicular yolk sac cancer depends on how far the cancer has spread and includes surgery (removal of the testicle), radiation therapy, and chemotherapy. Testicular yolk sac cancer is highly treatable and has a high rate of success. Testicular cancer can be detected early by performing a monthly testicular self-examination.
Who are the top Testicular Yolk Sac Tumor Local Doctors?
Distinguished in Testicular Yolk Sac Tumor
Hematology | Oncology
Distinguished in Testicular Yolk Sac Tumor
Hematology | Oncology
Referral may be required

UCI Health Chao Family Comprehensive Cancer Center

101 The City Drive South, Building 23, 
Orange, CA 
Languages Spoken:
English, Romanian

Mihaela Cristea is a Hematologist and an Oncologist practicing medicine in Orange, California. Dr. Cristea is rated as a Distinguished provider by MediFind in the treatment of Testicular Yolk Sac Tumor. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Lung Cancer, Virilizing Ovarian Tumor, and Endoscopy.

Distinguished in Testicular Yolk Sac Tumor
Gynecologic Oncology
Distinguished in Testicular Yolk Sac Tumor
Gynecologic Oncology
Referral required

Duke Cancer Center Gynecology Clinic

20 Duke Medicine Cir, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Andrew Berchuck is a Gynecologic Oncologist practicing medicine in Durham, North Carolina. Dr. Berchuck is rated as a Distinguished provider by MediFind in the treatment of Testicular Yolk Sac Tumor. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Oophorectomy, and Tubal Ligation. Dr. Berchuck is board certified in American Board Of Obstetrics/Gynecology, Obstetrics & Gynecology and American Board Of Obstetrics/Gynecology, Gynecologic Oncology. Dr. Berchuck is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Testicular Yolk Sac Tumor
Distinguished in Testicular Yolk Sac Tumor
Referral may be required

Prisma Health Cancer Institute – Faris Rd.

900 West Faris Road, 
Greenville, SC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Larry Puls is an Oncologist practicing medicine in Greenville, South Carolina. Dr. Puls is rated as a Distinguished provider by MediFind in the treatment of Testicular Yolk Sac Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Malignant Mixed Mullerian Tumor, Ovarian Cancer, Hernia Surgery, and Salpingo-Oophorectomy. Dr. Puls is board certified in American Board Of Obstetrics And Gynecology. Dr. Puls is currently accepting new patients.

What are the latest Testicular Yolk Sac Tumor Clinical Trials?
A Phase 1/2 Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Selected Advanced or Metastatic Solid Tumors

Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary antitumor activity of BGB-B2033 alone or in combination with tislelizumab, with or without bevacizumab, in adults with advanced or metastatic hepatocellular carcinoma (HCC), alpha-fetoprotein (AFP)-producing gastric cancer (GC), extragonadal yolk sac tumors, non-dysgermi...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors

Summary: This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of t...